Related Experiment Video
Updated: May 5, 2026

Author Spotlight: Developing a Disposable Dosator for Preclinical Testing of Dry Powder Inhalers in Small Animal Models
Published on: August 18, 2023
Alternative carriers in dry powder inhaler formulations
Yahya Rahimpour1, Maryam Kouhsoltani2, Hamed Hamishehkar3
1Biotechnology Research Center and Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran.
Choosing the right carrier powder is crucial for effective dry powder inhaler (DPI) drug delivery. This review explores alternatives to lactose, highlighting their pros and cons for improved pulmonary deposition.
Area of Science:
- Pharmaceutical Sciences
- Drug Delivery
- Materials Science
Background:
- Powder aerosolization efficiency for dry powder inhalers (DPIs) depends on carrier properties like particle size, shape, and surface.
- Achieving high and reproducible pulmonary deposition is a primary goal in inhalation therapy.
- Lactose is a common DPI carrier but has limitations with specific drugs and peptides.
Purpose of the Study:
- To critically review alternative carrier materials to lactose for DPI formulations.
- To analyze the merits, demerits, and applications of these alternative carriers.
- To provide insights for optimizing DPI formulation development.
Main Methods:
- Literature review of alternative carrier materials for DPIs.
- Critical analysis of carrier properties influencing aerosolization and pulmonary deposition.
- Comparative assessment of lactose versus alternative carriers.
Main Results:
- Several alternative carriers to lactose exist, each with unique advantages and disadvantages.
- Carrier properties significantly impact drug aerosolization and lung delivery performance.
- Optimizing carrier selection and processing is key to successful DPI formulation.
Conclusions:
- Alternative carriers offer solutions where lactose is unsuitable for DPI formulations.
- Careful selection and processing of carriers are essential for efficient pulmonary drug delivery.
- This review provides a guide for selecting appropriate DPI carriers beyond lactose.
Related Concept Videos
Inhaled Medications
Drug Delivery: Miscellaneous Routes
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Oral Drug Delivery Systems: Introduction
Additional Routes of Drug Administration
Administering drugs via inhalation allows for the direct delivery of gaseous, volatile substances or droplets to different parts of the respiratory tract. One of the advantages of the inhalation route is the rapid absorption of drugs into the circulatory system, which is possible because of the large surface area of...
Site-Targeted Drug Delivery Systems: Polymeric Carriers

